首页 | 本学科首页   官方微博 | 高级检索  
检索        

血塞通应用于脑梗死治疗的临床效果及机制探讨
引用本文:谢慧玲.血塞通应用于脑梗死治疗的临床效果及机制探讨[J].中国当代医药,2013(15):61-62.
作者姓名:谢慧玲
作者单位:广东省从化市中心医院重症医学科,广东从化510900
摘    要:目的 探讨血塞通注射液对于脑梗死患者神经功能的影响.方法 将本院收治的60例急性脑梗死患者随机分为实验组与对照组,两组患者均给予脑梗死常规治疗措施,实验组患者在此基础上给予血塞通注射液.比较两组患者治疗前后血浆纤维蛋白原水平、神经功能缺损评分及日常生活能力评分(Barthel评分),并评价两组患者的临床疗效.结果 实验组患者治疗后血浆纤维蛋白原水平、神经功能缺损评分显著低于对照组(P 〈 0.05),治疗有效率、Barthel评分显著高于对照组(P 〈 0.05).结论 血塞通能够显著改善脑梗死患者的神经功能及日常生活能力,提高患者的临床疗效,值得临床推广应用.

关 键 词:血塞通  脑梗死  临床疗效  机制

Clinical effect and mechanism of Xuesaitong applied to cerebral infarction
Authors:XIE Huiling
Institution:XIE Huiling Department of Critical Care Medicine, Central Hospital of Conghua City in Guangdong Province, Conghua 510900, China
Abstract:Objective To investigate the effect of neurological function of Xuesaitong injection for patients with acute cerebral infarction and. Methods Sixty cases of acute cerebral infarction in our hospital were randomly divided into experimental group and control group, the two groups of patients were given conventional treatment measures. Patients of experimental group were given Xuesaitong injection in addition. Plasma fibrinogen levels, neurological deficit scores and activities of daily living (Barthel score) of the two groups were compared before and after treatment, and the clinical efficacy of the two groups was evaluated. Results Plasma fibrinogen levels, neurological deficit scores of the experimental group were significantly lower than the control group (P 〈 0.05), and the efficacy rate, the Barthel score was significantly higher than the control group (P 〈 0.05). Conclusion Xuesaitong can significantly improve the neurologi- cal function, clinical efficacy and daily living skills of patients with cerebral infarction, which is worthy of clinical application.
Keywords:Xuesaitong  Cerebral infarction  Clinical efficacy  Mechanism
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号